Hsian-Rong Tseng

Dr. Hsian-Rong (HR) Tseng is currently a Professor in the Department of Molecular & Medical Pharmacology in David Geffen School of Medicine at UCLA. He also holds memberships in the California NanoSystems Institute, Crump Institute for Molecular Imaging, and Jonsson Comprehensive Cancer Center on the UCLA campus. Dr. Tseng has over 34 years of experience in organic chemistry, covering synthetic methodology, organometallic, supramolecular and radiochemistry, as well as 24 years of experience in micro- and nanofabrication for applications in biomedical devices. To translate liquid biopsy-based diagnostic technologies into the clinical setting, he has established an extensive collaboration network with oncology programs at UCLA and Cedars Sinai Medical Center, and other medical institutions in the US. To facilitate the commercial transition of in vitro diagnostics, he founded CytoLumina Technologies Corp. and Eximius Diagnostics. The NanoVelcro Chips, a product of CytoLumina, were recognized as a Success Story by the National Cancer Institute's Innovative Molecular Analysis Technologies program in October 2019. In December 2022, the FDA awarded Breakthrough Device Designation to the Liver Cancer Test developed by Eximius Dx, a step that will fast-track its FDA approval process.